Kelsey Financial’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Other funds holding ACAD
BBA
Kelsey Financial's ACAD Position: Q3 2026 in Review
Kelsey Financial held its Acadia Pharmaceuticals (ACAD) position steady in Q3 2026 at 10,000 shares worth $202K. The position accounts for 0.16% of the portfolio, ranked #62.
Kelsey Financial first reported a position in ACAD in Q4 2025 and has held it in 4 quarters since. The position peaked at $267K in Q4 2025. 351 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.
- Kelsey Financial held 10,000 shares of Acadia Pharmaceuticals worth $202K as of Q3 2026.
- Kelsey Financial left its Acadia Pharmaceuticals share count unchanged in Q3 2026.
- Acadia Pharmaceuticals made up 0.16% of Kelsey Financial's portfolio in Q3 2026, its #62 holding.
- Kelsey Financial first reported a position in Acadia Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- Kelsey Financial's Acadia Pharmaceuticals position peaked at $267K in Q4 2025.
- 351 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.
Based on Kelsey Financial's 13F filing for Q3 2026, filed 28 Oct 2026.